Modeling factors critical for implementation of precision medicine at health systems-level: an IRT approach
- PMID: 34956473
- PMCID: PMC8661177
Modeling factors critical for implementation of precision medicine at health systems-level: an IRT approach
Abstract
Background: Through recent advances in omics technologies, precision medicine (PM) promises to fundamentally change the way we approach health, disease and illness. Imperative applications of omics-based biomarkers are gradually moving from research to clinical settings, with huge long-term clinical and public health implications. Whereas much of research in PM is mainly focused on basic biomedical discoveries, currently there is little research on the clinical implementation of omics biomarkers, especially at health systems level.
Aim and methods: This study investigated the application of multidimensional item response theory (IRT) models to validate a hypothesized PM implementation measurement model. This is a contribution to PM implementation at health systems level. Data obtained through an item-sort procedure involving 496 observations from 124 study participants formed the basis of a 22-item PMI measurement model.
Conclusion: Statistical significance of the bifactor model suggests PM implementation may have to be examined using factors that reflect a single common underlying implementation construct, as well as factors that reflect unique variances for the identified four content-specific factors.
Keywords: IRT; Precision medicine; bifactor modelling; implementation model; omics technologies.
AJTR Copyright © 2021.
Conflict of interest statement
None.
Figures





References
-
- Horgan RP, Kenny LC. ‘Omic’ technologies: genomics, transcriptomics, proteomics and metabolomics. Obste Gynaecol. 2011;13:189–195.
-
- Vernon ST, Hansen T, Kott KA, Yang JY, O’Sullivan JF, Figtree GA. Utilizing state-of-the-art “omics” technology and bioinformatics to identify new biological mechanisms and biomarkers for coronary artery disease. Microcirculation. 2019;26:e12488. - PubMed
-
- Ptolemy AS, Rifai N. What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema. Scand J Clin Lab Invest Suppl. 2010;70:6–14. - PubMed
LinkOut - more resources
Full Text Sources